Intravitreal triamcinolone in the treatment of serous pigment epithelial detachment and occult choroidal neovascularization secondary to age-related macular degeneration.
about
Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatmentClinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept.
P2860
Intravitreal triamcinolone in the treatment of serous pigment epithelial detachment and occult choroidal neovascularization secondary to age-related macular degeneration.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Intravitreal triamcinolone in ...... -related macular degeneration.
@en
type
label
Intravitreal triamcinolone in ...... -related macular degeneration.
@en
prefLabel
Intravitreal triamcinolone in ...... -related macular degeneration.
@en
P2093
P1476
Intravitreal triamcinolone in ...... -related macular degeneration.
@en
P2093
P304
P577
2005-05-01T00:00:00Z